The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / January / How to Test Whether Antibiotics Actually Work
Microbiology & Immunology Infectious Disease Microscopy and imaging Research and Innovations

How to Test Whether Antibiotics Actually Work

New testing method predicts antibiotic treatment success by measuring bacterial killing speed

01/16/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: How to Test Whether Antibiotics Actually Work

At a Glance

CategoryDetail
ConditionBacterial Infections
Key MechanismsSpeed of bacterial death and drug tolerance determine treatment outcomes.
Target PopulationPatients with tuberculosis and Mycobacterium abscessus infections.
Care SettingClinical laboratories and microbiology departments.

Key Highlights

  • Antimicrobial Single-Cell Testing (ASCT) tracks bacterial death rates under antibiotic exposure.
  • Drug tolerance is genetically determined and linked to treatment failures.
  • Combining MIC results with killing speed improves prediction of patient outcomes.
  • Bedaquiline and pretomanid show superior performance under starvation conditions.
  • The platform allows simultaneous testing of multiple strains against various antibiotics.

Guideline-Based Recommendations

Diagnosis

  • Utilize ASCT for more accurate assessment of antibiotic efficacy.

Management

  • Incorporate killing speed measurements alongside MIC for personalized treatment.

Monitoring & Follow-up

  • Regularly assess bacterial response to antibiotics using time-kill curves.

Risks

  • Relying solely on conventional susceptibility tests may lead to treatment failures.

Patient & Prescribing Data

Patients with difficult-to-treat bacterial infections.

Personalized antibiotic selection based on genetic tolerance and killing speed.

Clinical Best Practices

  • Combine MIC testing with ASCT for improved treatment predictions.
  • Monitor bacterial strains for genetic markers of drug tolerance.
  • Consider starvation conditions when evaluating antibiotic effectiveness.

Related Resources & Content

  • Nature Microbiology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.